journal article·2025-01-01

Multidimensional nanofibrous hydrogels integrated triculture system for advanced myocardial regeneration

Dongwoo Kim, Yeong Hwan Kim, Gyubok Lee, Eun-Cheol Lee, Suk Ho Bhang, Kangwon Lee

Biofabrication· Volume 17· Issue 1
Publisher page

Abstract

Abstract Myocardial infarction (MI) remains a leading cause of mortality worldwide, posing a significant challenge to healthcare systems. The limited regenerative capacity of cardiac tissue following MI results in chronic cardiac dysfunction, highlighting the urgent need for innovative therapeutic strategies. In this study, we explored the application of a multidimensional nanofibrous hydrogel for myocardial regeneration. We developed a composite hydrogel system by integrating fibrin, polycaprolactone (PCL), and alginate. In this system, fibrin supported cell proliferation and significantly enhanced angiogenesis when combined with human umbilical vein endothelial cells (HUVECs). PCL contributed to the alignment of encapsulated cells, improving their organization within the scaffold. Adipose-derived stem cells (ADSCs) were encapsulated within the hydrogel for their versatile regenerative potential, while C2C12 cells were incorporated for their ability to form muscle tissue. Additionally, the inclusion of alginate not only enhanced the mechanical properties of the hydrogel to better match the biomechanical demands of cardiac tissue but also played a critical role in reducing the immune response, thereby improving the system’s biocompatibility. This study presents an advanced platform for myocardial regeneration using a nanofibrous hydrogel system designed to meet the dual requirements of mechanical robustness and cellular compatibility essential for cardiac tissue engineering. The triculture system, consisting of ADSCs, C2C12 cells, and HUVECs, harnesses the regenerative capabilities of each cell type, promoting both angiogenesis and tissue regeneration. This comprehensive approach addresses the immediate needs for cellular survival and integration while effectively overcoming long-term mechanical and immunological challenges.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (55)

Show source-provided references
1. Global trends in atherosclerotic cardiovascular disease10.1016/j.clinthera.2023.09.020 ↗
2. Regenerative strategies for the consequences of myocardial infarction: chronological indication and upcoming visions10.1016/j.biopha.2021.112584 ↗
3. Invasive management of acute myocardial infarction complicated by cardiogenic shock: a scientific statement from the american heart association10.1161/CIR.0000000000000959 ↗
4. Desktop 3D printed anatomic models for minimally invasive direct coronary artery bypass10.1186/s41205-024-00222-1 ↗
5. Minimally invasive direct coronary artery bypass versus percutaneous coronary intervention for isolated left anterior descending artery stenosis: an updated meta-analysis10.1532/hsf.5211 ↗
6. Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration10.1016/j.bioactmat.2020.10.021 ↗
7. Constructing a cell microenvironment with biomaterial scaffolds for stem cell therapy10.1186/s13287-021-02650-w ↗
8. Stem cell-based approaches in cardiac tissue engineering: controlling the microenvironment for autologous cells10.1016/j.biopha.2021.111425 ↗
9. Stem cell-based therapy in cardiac repair after myocardial infarction: promise, challenges, and future directions10.1016/j.yjmcc.2023.12.009 ↗
10. Cardiac tissue engineering: state-of-the-art methods and outlook10.1186/s13036-019-0185-0 ↗
11. A multimodal scaffold for tissue integration and SDF-1 delivery improves cardiac function in a rat model of subacute myocardial infarction10.1021/acsami.3c04245 ↗
12. A degradable, bioactive, gelatinized alginate hydrogel to improve stem cell/growth factor delivery and facilitate healing after myocardial infarction10.1016/j.mehy.2012.08.006 ↗
13. Biomaterials engineered for integration10.1016/S1369-7021(08)70089-0 ↗
14. A novel polyurethane/cellulose fibrous scaffold for cardiac tissue engineering10.1039/C4RA12486C ↗
15. Collagen hydrogel containing polyethylenimine-gold nanoparticles for drug release and enhanced beating properties of engineered cardiac tissues10.1002/adhm.202202408 ↗
16. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance10.1152/ajpheart.01017.2005 ↗
17. Scaffold-based developmental tissue engineering strategies for ectodermal organ regeneration10.1016/j.mtbio.2021.100107 ↗
18. Fibrin structure and wound healing10.1111/j.1538-7836.2006.01861.x ↗
19. An characterization of a PCL-fibrin scaffold for myocardial repair10.1016/j.mtcomm.2023.107596 ↗
20. Alginate hydrogels as scaffolds and delivery systems to repair the damaged spinal cord10.1002/biot.201900275 ↗
21. Alginate-based hydrogels as drug delivery vehicles in cancer treatment and their applications in wound dressing and 3D bioprinting10.1186/s13036-020-0227-7 ↗
22. Enhanced vascular-like network formation of encapsulated HUVECs and ADSCs coculture in growth factors conjugated GelMA hydrogels10.1021/acsbiomaterials.4c00465 ↗
23. Optimum performance of a novel biocompatible scaffold comprising alginate-pectin-selenium nanoparticles for cardiac tissue engineering using C2C12 cells10.1016/j.molstruc.2023.136457 ↗
24. In vivo study to assess dosage of allogeneic pig retinal progenitor cells: long-term survival, engraftment, differentiation and safety10.1111/jcmm.17332 ↗
25. Differentiation and long-term survival of C2c12 myoblast grafts in heart10.1172/JCI116734 ↗
26. 4D printed cardiac construct with aligned myofibers and adjustable curvature for myocardial regeneration10.1021/acsami.0c17610 ↗
27. Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes10.1042/BSR20200833 ↗
28. Co-culture of human umbilical vein endothelial cells and human bone marrow stromal cells into a micro-cavitary gelatin-methacrylate hydrogel system to enhance angiogenesis10.1016/j.msec.2019.04.089 ↗
29. Enhanced in vitro angiogenic behaviour of human umbilical vein endothelial cells on thermally oxidized TiO nanofibrous surfaces10.1038/srep21828 ↗
30. Hydrogel/nanofiber composite wound dressing optimized for skin layer regeneration through the mechanotransduction-based microcellular environment10.1021/acsabm.3c00014 ↗
31. Hypoxia potentiated pro-angiogenic and anti-fibrotic effect of nanovesicles derived from human mesenchymal stem cells10.1016/j.jiec.2024.03.038 ↗
32. Cardiac tissue engineering for myocardial infarction treatment10.1016/j.ejps.2023.106439 ↗
33. 2D and 3D cell cultures—a comparison of different types of cancer cell cultures10.5114/aoms.2016.63743 ↗
34. vascularization of hydrogel-based tissue constructs via a combined approach of cell sheet engineering and dynamic perfusion cell culture10.1088/1758-5090/ac9433 ↗
35. Hypoxia-inducible factor 1 alpha (HIF-1α)/vascular endothelial growth factor (VEGF) pathway participates in angiogenesis of myocardial infarction in muscone-treated mice: preliminary study10.12659/MSM.912051 ↗
36. Advancements in myocardial infarction management: exploring novel approaches and strategies10.7759/cureus.45578 ↗
37. Myocardial recovery with mechanical circulatory support10.1002/ejhf.575 ↗
38. Hydrogel-based cardiac repair and regeneration function in the treatment of myocardial infarction10.1016/j.mtbio.2024.100978 ↗
39. Teichmann, cells of the adult human heart10.1038/s41586-020-2797-4 ↗
40. Prospects of hydrogels in agriculture for enhancing crop and water productivity under water deficit condition10.1155/2022/4914836 ↗
41. Bone tissue engineering scaffolds with HUVECs/hBMSCs cocultured on 3D-printed composite bioactive ceramic scaffolds promoted osteogenesis/angiogenesis10.1016/j.jot.2022.10.008 ↗
42. 3D in vitro synovial hyperplasia model on polycaprolactone-micropatterned nanofibrous microwells for screening disease-modifying anti-rheumatic drugs10.1016/j.mtbio.2024.101061 ↗
43. Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: implications for angiogenesis10.1016/S1050-1738(99)00014-6 ↗
44. Enhanced therapeutic neovascularization by CD31-expressing cells and embryonic stem cell-derived endothelial cells engineered with chitosan hydrogel containing VEGF-releasing microtubes10.1016/j.biomaterials.2015.06.009 ↗
45. FGF-2 promotes angiogenesis through a SRSF1/SRSF3/SRPK1-dependent axis that controls VEGFR1 splicing in endothelial cells10.1186/s12915-021-01103-3 ↗
46. microRNA-126 inhibits tube formation of HUVECs by interacting with and down-regulating PI3K/AKT signaling pathway10.1016/j.biopha.2019.109007 ↗
47. Modulation of anti-cardiac fibrosis immune responses by changing M2 macrophages into M1 macrophages10.1186/s10020-024-00858-z ↗
48. Screening mutations in myosin binding protein C3 gene in a cohort of patients with hypertrophic cardiomyopathy10.1186/1471-2350-11-67 ↗
49. Identification and functional analysis of variants of gene promoter in isolated ventricular septal defects10.1186/s12920-022-01365-y ↗
50. Region of Interest analysis using mass spectrometry imaging of mitochondrial and sarcomeric proteins in acute cardiac infarction tissue10.1038/s41598-018-25817-7 ↗
51. Cardiac troponin T as a postmortem biomarker for acute myocardial infarction10.1016/j.forsciint.2022.111506 ↗
52. Skeletal muscle cells adopt cardiac-like sodium current properties in a cardiac cell environment10.1152/ajpheart.00119.2006 ↗
53. Endothelial network formation within human tissue-engineered skeletal muscle10.1089/ten.tea.2015.0093 ↗
54. Angiogenic potential of skeletal muscle derived extracellular vesicles differs between oxidative and glycolytic muscle tissue in mice10.1038/s41598-023-45787-9 ↗
55. Micro/nano-hierarchical scaffold fabricated using a cell electrospinning/3D printing process for co-culturing myoblasts and HUVECs to induce myoblast alignment and differentiation10.1016/j.actbio.2020.02.042 ↗